Surgery plays a vital role not only in saving lives but in restoring patients’ quality of life (QOL). However, microsurgery advanced procedures performed under a microscope demands exceptional dexterity and expertise. Consequently, these life-changing treatments are often limited to a select few specialists, creating significant disparities in patient care. At Qoly, we believe robotics can unlock the full potential of a surgeon's skill. By enabling safer, more precise procedures, we are dedicated to democratizing access to microsurgical care and improving outcomes for patients worldwide.
| Company Name | Qoly Corporation |
|---|---|
| President | Yohei Kuroda |
| Board of Directors |
Yohei Kuroda, Founder & CEO Kazuhito Wakana, Founder & CTO Tomohiro Anzai, External Director Hajime Oshita, External Director Tomoyo Mori, Corporate Auditor |
| Established | October 1, 2025 |
| Headquarters | 3-6-4 Osaki, Shinagawa-ku, Tokyo, Japan |
| Paid-in Capital | JPY 909 million |
| Main Business Activities |
Development, manufacturing, sales, and support of microsurgical robotic systems. |
| Investors |
・Fast Track Initiative, Inc. ・MedVenture Partners, Inc. ・Sony Group Corporation ・Development Bank of Japan Inc. |
At Qoly, we are a team of professionals dedicated to creating essential value in healthcare. Through mutual respect, open dialogue, and rigorous validation, we turn impactful technologies into reality—delivering solutions that matter in clinical settings.We believe progress isn't just thought; it’s built. We test, we challenge assumptions, and we continuously learn. Every step we take strengthens the tools that support surgeons and the patients they serve.
